ZipRecruiter

Log In

1

Freelance Biotech Investor Relations Jobs (NOW HIRING)

United Therapeutics Corporation

$90 - $130/hr

Who We AreWe are the first publicly-traded biotech or pharmaceutical company to take the form of a public benefit corporation. Our public benefit purpose is to provide a brighter future for patients ...

Travere

Analyst, Investor Relations

San Diego, CA

Department: 101200 Investor Relations Location: San Diego Be a part of a global team that is ... Strong interest in capital markets, investing, biotechnology, healthcare, and current events ...

next page

Showing results 1-20

All Jobsfreelance JobsFinance and Insurance JobsFinancial Services JobsInvestor Relations Associate JobsFreelance Biotech Investor Relations Jobs

Freelance Biotech Investor Relations information

See salary details

$31K

$101.1K

$191K

How much do freelance biotech investor relations jobs pay per year?

As of Aug 30, 2026, the average yearly pay for freelance biotech investor relations in the United States is $101,099.00, according to ZipRecruiter salary data. Most workers in this role earn between $62,000.00 and $134,500.00 per year, depending on experience, location, and employer.

What is a freelance biotech investor relations professional?

Freelance biotech investor relations professionals are independent specialists who help biotechnology companies communicate with investors, analysts, and the financial community. They work on a contract basis rather than as full-time employees, providing expertise in preparing press releases, organizing investor meetings, and crafting financial reports. Their role is crucial for building investor confidence, explaining complex scientific concepts in accessible language, and ensuring compliance with financial regulations. By working freelance, they offer flexibility and specialized support to growing or resource-limited biotech firms.

What are the key skills and qualifications needed to thrive as a freelance biotech investor relations professional?

To thrive as a Freelance Biotech Investor Relations specialist, you need a solid understanding of biotechnology, financial markets, and investor communications, often backed by a degree in life sciences, finance, or communications. Familiarity with investor relations management platforms, financial reporting tools, and SEC filing systems is typically required. Exceptional interpersonal, presentation, and networking skills help build trust with investors and effectively convey complex scientific information. These skills are crucial for attracting investment, maintaining regulatory compliance, and supporting the growth of biotech companies.

What are some common challenges faced by freelance biotech investor relations professionals, and how can they be addressed?

Freelance biotech investor relations professionals often face challenges such as staying updated on rapidly evolving scientific developments, building credibility with investors without the backing of a large firm, and managing multiple client accounts simultaneously. To address these, it's important to continuously educate oneself on industry trends, establish strong communication channels with both clients and investors, and leverage digital tools to organize workflow and maintain transparency. Networking within the biotech and finance communities can also help build trust and open up new opportunities.

What is the difference between Freelance Biotech Investor Relations vs Biotech Communications Specialist?

AspectFreelance Biotech Investor RelationsBiotech Communications Specialist
CredentialsBiotech knowledge, investor relations experience, communication skillsBiotech knowledge, communication skills, media relations
Work EnvironmentRemote, freelance, project-basedAgency or in-house, often office-based or remote
Employer & Industry UsageBiotech firms, investors, consulting firmsBiotech companies, PR agencies, media outlets

Freelance Biotech Investor Relations professionals focus on managing relationships with investors, providing financial updates, and supporting funding efforts. Biotech Communications Specialists handle media relations, public messaging, and brand reputation. While both roles require biotech knowledge and communication skills, investor relations is more finance-oriented, whereas communications focus on media and public perception.

More about Freelance Biotech Investor Relations jobs

What cities are hiring for Freelance Biotech Investor Relations jobs?

Cities with the most Freelance Biotech Investor Relations job openings:

What are the most commonly searched types of Biotech Investor Relations jobs?

The most popular types of Biotech Investor Relations jobs are:

What states have the most Freelance Biotech Investor Relations jobs?

States with the most job openings for Freelance Biotech Investor Relations jobs include:

What job categories do people searching Freelance Biotech Investor Relations jobs look for?

The top searched job categories for Freelance Biotech Investor Relations jobs are:

Freelance Biotech Investor Relations jobs near you
Infographic showing various Freelance Biotech Investor Relations job openings in the United States as of August 2026, with employment types broken down into 1% As Needed, 84% Full Time, 13% Part Time, 1% Temporary, and 1% Contract. Highlights an 92% Physical, 2% Hybrid, and 6% Remote job distribution, with an average salary of $101,099 per year, or $48.6 per hour.

Director or Senior Director, Investor Relations and Communications

California, MD • On-site

Scorpion Therapeutics
51 - 200 employees
Learn more about Scorpion Therapeuticsexternal

$220 - $300/hr

Other

Posted yesterday

New

Job description

POSITION SUMMARY:

  • Formulate an integrated vision and strategy for communicating effectively with the investor community to drive positive brand recognition and strong investor interest.


KEY ROLE AND RESPONSIBILITIES:

  • Collaborate with C-suite and product teams to develop and execute investor communications strategy (quarterly filings, conference calls, investor conferences, roadshows).

  • Lead a comprehensive strategic/tactical communications plan for investor relations objectives.

  • Ensure effective, consistent corporate communications and keep strategy/progress top of mind.

  • Partner with Finance and Legal to ensure investor-facing communications are robust, timely, accurate, and compelling.

  • Develop key messages, FAQs, and talking points for investor/analyst events.

  • Train and advise spokespeople for media/press and industry presentations; prepare briefing materials.

  • Build relationships with analysts, investors, media, influencers, and partners; serve as an on-record spokesperson.

  • Partner with media/PR agency/external partners to develop and execute campaigns; monitor brand activity.

  • Manage proactive and responsive communications, including crisis communications and rapid response.

  • Track competitor and peer company announcements.


PREFERRED EDUCATION:

  • Bachelor’s degree in a scientific discipline (Communications/Marketing or related with significant biotech experience). Master’s degree a plus.


PREFERRED EXPERIENCE:

  • Senior Director: 10+ years PR (prefer investor relations), corporate communications, or media; 8+ years management/leadership.

  • Director: 7–9 years PR (prefer investor relations), corporate communications, or media; 5–7 years management/leadership.

  • Biotech investor relations/corporate communications or sell-side analyst experience; track record supporting financing, conferences, and product launches.


KNOWLEDGE, SKILLS AND ABILITIES:

  • Cross-functional leadership through complexity; influence multiple stakeholders.

  • Executive presence; strategic thinking with detail focus.

  • Prioritize and execute competing priorities in a fast-moving environment.

  • Strong written/verbal communication; tailor messages to diverse audiences; agile, sound judgment.

  • Willingness to “roll-up your sleeves” from strategy to execution.


COMPENSATION/OTHER:

  • Salary range: $220,000–$300,000 annually; annual bonus opportunity.

  • Eligible for Lyell’s Equity Incentive Plan.

#J-18808-Ljbffr

Apply